Respiratory Therapies Set to Drive Pharma Growth in Coming Months

Anti-diabetics and cardiac treatments are the main drivers of the domestic pharmaceutical market, with respiratory treatments projected to be the primary growth drivers in November, December, and January. With air pollution persisting, it is...

Glenmark Becomes First Indian Company to Launch Biosimilar of Liraglutide

Glenmark became the first Indian company to introduce a biosimilar of the anti-diabetic GLP-1 drug Liraglutide in India. Additionally, it has revealed a number of collaborations to introduce new drugs, such as partnerships with Jiangsu Alphamab...

Pharmanovia Secures Exclusive Rights for Innovative Antibody

The exclusive license agreement permits Pharmanovia to launch catumaxomab, a unique trifunctional bi-specific monoclonal antibody, for intraperitoneal treatment of malignant ascites in EpCAM-positive carcinoma patients ineligible for additional...

US Drives 30% Sales and 40% Volume for India Pharma

The United States continues to be a crucial market for the Indian pharmaceutical industry, representing approximately 30% of overall sales and capturing a 40% share of the market in terms of volume. Despite possible risks from changes in duty...

Pharma Blister Packaging Adopts Smart Tech for a Future-Ready Market

There is a noticeable shift towards smart packaging technologies in the pharmaceutical blister packaging market. The trend of incorporating digital functions like tracking products using smartphones and reminding patients to take medication on...

China Advances Pharma Innovation for Greater Drug Accessibility

China is upgrading its pharmaceutical industry to make drugs and healthcare more accessible. This is part of its plan to become more self-reliant through “new quality productive forces” driven by technical innovation and a supportive business...

SPI Initiative Powers Pharma Clusters & MSMEs with 500 Cr Support

Strengthening of Pharmaceutical Industry (SPI)' initiative, backed by Rs 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality and sustainability across pharma clusters and MSMEs nationwide....

India Leads as Largest Supplier of Generic Medicines with 20% Share

India holds the biggest share in global generic medicine supply with 20 percent, producing 60,000 generic brands in 60 therapeutic categories. Products made in the country are sent to more than 200 countries worldwide, with Japan, Australia...

India's Dialysis Market Faces High Costs with 3% APAC Share

The dialysis machines sector in India makes up around 3% of the Asia Pacific market, with the majority of machines being imported, leading to increased expenses. GlobalData reported that the market is expected to reach $14 million by 2033 due to...

Innovation and Biopharma Research Fuel Growth in Specialty Pharma Market

Continuous innovation and biopharmaceutical research are driving growth in the specialty pharmaceutical market. The industry's dedication to creating innovative treatment choices plays a crucial role in achieving better disease targeting with...

© 2024 India Pharma Outlook. All Rights Reserved.